GMM Pfaudler MD Tarak Patel on Company's Outlook

The video discusses the impact of the China plus one policy on global markets, highlighting increased investments in the chemical and pharmaceutical industries. It covers the company's revenue outlook, global expansion strategies, and the challenges posed by economic factors like inflation and supply chain disruptions. The diversification strategy, including recent acquisitions, is emphasized as a key growth driver.

What is the China plus one policy and how is it impacting equipment sourcing in Europe and the US?

Can you explain the recent trends in investment in the chemical and pharmaceutical industries?

What are the expected revenue contributions from exports in the coming year?

How is the company leveraging India as a low-cost sourcing hub?

How does the company plan to grow its market share in new regions?

What challenges are being faced due to high inflation and supply chain disruptions?

What is the company's strategy regarding mergers and acquisitions in the next financial year?